BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 27030717)

  • 1. Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain.
    Luo X; Tai WL; Sun L; Pan Z; Xia Z; Chung SK; Cheung CW
    Mol Pain; 2016; 12():. PubMed ID: 27030717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model.
    Liu ZY; Song ZW; Guo SW; He JS; Wang SY; Zhu JG; Yang HL; Liu JB
    CNS Neurosci Ther; 2019 Sep; 25(9):922-936. PubMed ID: 30955244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord.
    Li XQ; Zhang ZL; Tan WF; Sun XJ; Ma H
    PLoS One; 2016; 11(10):e0163807. PubMed ID: 27760212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Chemokine CXCL12 in the Dorsal Root Ganglia and Spinal Cord Contributes to the Development and Maintenance of Neuropathic Pain Following Spared Nerve Injury in Rats.
    Bai L; Wang X; Li Z; Kong C; Zhao Y; Qian JL; Kan Q; Zhang W; Xu JT
    Neurosci Bull; 2016 Feb; 32(1):27-40. PubMed ID: 26781879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice.
    Luo X; Tai WL; Sun L; Qiu Q; Xia Z; Chung SK; Cheung CW
    PLoS One; 2014; 9(8):e104860. PubMed ID: 25119456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.
    Shen W; Hu XM; Liu YN; Han Y; Chen LP; Wang CC; Song C
    J Neuroinflammation; 2014 Apr; 11():75. PubMed ID: 24735601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain.
    Dubový P; Klusáková I; Svízenská I; Brázda V
    Histochem Cell Biol; 2010 Mar; 133(3):323-37. PubMed ID: 20127490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis.
    Pan Z; Shan Q; Gu P; Wang XM; Tai LW; Sun M; Luo X; Sun L; Cheung CW
    J Neuroinflammation; 2018 Jan; 15(1):29. PubMed ID: 29386025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSV-mediated p55TNFSR reduces neuropathic pain induced by HIV gp120 in rats through CXCR4 activity.
    Huang W; Zheng W; Liu S; Zeng W; Levitt RC; Candiotti KA; Lubarsky DA; Hao S
    Gene Ther; 2014 Mar; 21(3):328-36. PubMed ID: 24451118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
    Hu XM; Liu YN; Zhang HL; Cao SB; Zhang T; Chen LP; Shen W
    J Neurochem; 2015 Feb; 132(4):452-63. PubMed ID: 25393328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CXCL12/CXCR4 signaling on neuropathic pain after chronic compression of dorsal root ganglion.
    Yu Y; Huang X; Di Y; Qu L; Fan N
    Sci Rep; 2017 Jul; 7(1):5707. PubMed ID: 28720830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte contributes to pain development via MMP2-JNK1/2 signaling in a mouse model of complex regional pain syndrome.
    Tian G; Luo X; Tang C; Cheng X; Chung SK; Xia Z; Cheung CW; Guo Q
    Life Sci; 2017 Feb; 170():64-71. PubMed ID: 27919822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice.
    Morioka N; Zhang FF; Nakamura Y; Kitamura T; Hisaoka-Nakashima K; Nakata Y
    Brain Behav Immun; 2015 Oct; 49():293-310. PubMed ID: 26116449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loganin prevents CXCL12/CXCR4-regulated neuropathic pain via the NLRP3 inflammasome axis in nerve-injured rats.
    Cheng KI; Chen SL; Hsu JH; Cheng YC; Chang YC; Lee CH; Yeh JL; Dai ZK; Wu BN
    Phytomedicine; 2021 Nov; 92():153734. PubMed ID: 34536822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
    Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
    J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of CXCL1 in the glial cells during neuropathic pain.
    Moraes TR; Elisei LS; Malta IH; Galdino G
    Eur J Pharmacol; 2020 May; 875():173039. PubMed ID: 32119843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulating miR-130a-5p relieves astrocyte over activation-induced neuropathic pain through targeting C-X-C motif chemokine receptor 12/C-X-C motif chemokine receptor 4 axis.
    Dong J; Xu C; Xia R; Zhang Z
    Neuroreport; 2021 Jan; 32(2):135-143. PubMed ID: 33395188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL12/CXCR4 signaling mediated ERK1/2 activation in spinal cord contributes to the pathogenesis of postsurgical pain in rats.
    Xing F; Kong C; Bai L; Qian J; Yuan J; Li Z; Zhang W; Xu JT
    Mol Pain; 2017; 13():1744806917718753. PubMed ID: 28633557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation.
    Xie F; Wang Y; Li X; Chao YC; Yue Y
    Neurochem Res; 2016 Sep; 41(9):2289-99. PubMed ID: 27168326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of microglial chemokine CXCL12 in anterior cingulate cortex mediates neuropathic pain in diabetic mice.
    Song ZH; Song XJ; Yang CL; Cao P; Mao Y; Jin Y; Xu MY; Wang HT; Zhu X; Wang W; Zhang Z; Tao WJ
    Acta Pharmacol Sin; 2023 Jul; 44(7):1337-1349. PubMed ID: 36697977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.